Semantic Scholar uses AI to extract papers important to this topic.
We introduce the ForceGen method for 3D structure generation and conformer elaboration of drug-like small molecules. ForceGen is… Expand Hepatitis C virus (HCV) NS3/4A protease is an important and attractive target for anti-HCV drug development and discovery… Expand BACKGROUND & AIMS
The combination of vaniprevir (a NS3/4A protease inhibitor) with peginterferon and ribavirin was shown to… Expand Vaniprevir is a competitive inhibitor of the hepatitis C virus (HCV) NS3/4A protease that has potent anti-HCV activity in… Expand BACKGROUND
Vaniprevir with P/R improved SVR rates over P/R alone in treatment-experienced patients with chronic HCV-genotype 1… Expand Hepatitis C virus (HCV) infects over 170 million people worldwide and is the leading cause of chronic liver diseases, including… Expand Vaniprevir (MK‐7009) is a macrocyclic hepatitis C virus (HCV) nonstructural protein 3/4A protease inhibitor. The aim of the… Expand A highly efficient synthesis of Vaniprevir (MK-7009) has been accomplished in nine linear steps and 55% overall yield. The key… Expand BACKGROUND & AIMS
The hepatitis C virus (HCV) genotype influences efficacy of interferon (IFN)-based therapy. HCV protease… Expand A new class of HCV NS3/4a protease inhibitors which contain a P2 to P4 macrocyclic constraint was designed using a molecular… Expand